Loading...
XJPX
7575
Market cap691mUSD
Dec 05, Last price  
1,532.00JPY
1D
0.79%
1Q
0.52%
Jan 2017
31.45%
Name

Japan Lifeline Co Ltd

Chart & Performance

D1W1MN
XJPX:7575 chart
P/E
11.53
P/S
1.90
EPS
132.89
Div Yield, %
2.74%
Shrs. gr., 5y
-2.45%
Rev. gr., 5y
1.81%
Revenues
56.61b
+10.17%
19,192,536,00018,146,138,00019,840,908,00019,840,909,00022,089,972,00022,361,621,00023,140,947,00021,944,430,00024,371,000,00025,696,000,00030,540,000,00037,181,000,00042,298,000,00045,525,000,00051,761,000,00051,286,000,00051,469,000,00051,750,000,00051,384,000,00056,610,000,000
Net income
9.32b
+23.98%
777,462,000508,453,000236,226,000236,226,000562,795,000772,993,000720,517,000519,726,000-202,000,0001,124,000,0002,804,000,0005,350,000,0007,478,000,0007,723,000,0007,748,000,0002,000,000,0007,484,000,0006,891,000,0007,515,000,0009,317,000,000
CFO
9.11b
+31.73%
562,622,000358,554,000-169,851,000-169,851,000611,838,0001,273,320,0001,353,624,000816,550,000-374,000,0001,245,000,000916,000,0006,584,000,0004,450,000,0007,037,000,0007,096,000,00011,432,000,00010,246,000,00011,201,000,0006,918,000,0009,113,000,000
Dividend
Mar 30, 202654 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
IPO date
Dec 08, 1997
Employees
1,166
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT